Copyright Reports & Markets. All rights reserved.

Global Diabetic Peripheral Neuropathy Treatment Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Diabetic Peripheral Neuropathy Treatment Market Overview

      • 1.1 Product Overview and Scope of Diabetic Peripheral Neuropathy Treatment
      • 1.2 Diabetic Peripheral Neuropathy Treatment Segment by Type
        • 1.2.1 Global Diabetic Peripheral Neuropathy Treatment Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Antimunocel
        • 1.2.3 ASP-8477
        • 1.2.4 BNV-222
        • 1.2.5 Capsaicin
        • 1.2.6 CBX-129801
        • 1.2.7 Others
      • 1.3 Diabetic Peripheral Neuropathy Treatment Segment by Application
        • 1.3.1 Diabetic Peripheral Neuropathy Treatment Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.3 Global Diabetic Peripheral Neuropathy Treatment Market by Region
        • 1.3.1 Global Diabetic Peripheral Neuropathy Treatment Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Diabetic Peripheral Neuropathy Treatment Market Size
        • 1.4.1 Global Diabetic Peripheral Neuropathy Treatment Revenue (2014-2025)
        • 1.4.2 Global Diabetic Peripheral Neuropathy Treatment Production (2014-2025)

      2 Global Diabetic Peripheral Neuropathy Treatment Market Competition by Manufacturers

      • 2.1 Global Diabetic Peripheral Neuropathy Treatment Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Diabetic Peripheral Neuropathy Treatment Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Diabetic Peripheral Neuropathy Treatment Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Diabetic Peripheral Neuropathy Treatment Production Sites, Area Served, Product Types
      • 2.5 Diabetic Peripheral Neuropathy Treatment Market Competitive Situation and Trends
        • 2.5.1 Diabetic Peripheral Neuropathy Treatment Market Concentration Rate
        • 2.5.2 Diabetic Peripheral Neuropathy Treatment Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Diabetic Peripheral Neuropathy Treatment Production Market Share by Regions

      • 3.1 Global Diabetic Peripheral Neuropathy Treatment Production Market Share by Regions
      • 3.2 Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Diabetic Peripheral Neuropathy Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Diabetic Peripheral Neuropathy Treatment Production
        • 3.4.1 North America Diabetic Peripheral Neuropathy Treatment Production Growth Rate (2014-2019)
        • 3.4.2 North America Diabetic Peripheral Neuropathy Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Diabetic Peripheral Neuropathy Treatment Production
        • 3.5.1 Europe Diabetic Peripheral Neuropathy Treatment Production Growth Rate (2014-2019)
        • 3.5.2 Europe Diabetic Peripheral Neuropathy Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Diabetic Peripheral Neuropathy Treatment Production (2014-2019)
        • 3.6.1 China Diabetic Peripheral Neuropathy Treatment Production Growth Rate (2014-2019)
        • 3.6.2 China Diabetic Peripheral Neuropathy Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Diabetic Peripheral Neuropathy Treatment Production (2014-2019)
        • 3.7.1 Japan Diabetic Peripheral Neuropathy Treatment Production Growth Rate (2014-2019)
        • 3.7.2 Japan Diabetic Peripheral Neuropathy Treatment Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Diabetic Peripheral Neuropathy Treatment Consumption by Regions

      • 4.1 Global Diabetic Peripheral Neuropathy Treatment Consumption by Regions
      • 4.2 North America Diabetic Peripheral Neuropathy Treatment Consumption (2014-2019)
      • 4.3 Europe Diabetic Peripheral Neuropathy Treatment Consumption (2014-2019)
      • 4.4 China Diabetic Peripheral Neuropathy Treatment Consumption (2014-2019)
      • 4.5 Japan Diabetic Peripheral Neuropathy Treatment Consumption (2014-2019)

      5 Global Diabetic Peripheral Neuropathy Treatment Production, Revenue, Price Trend by Type

      • 5.1 Global Diabetic Peripheral Neuropathy Treatment Production Market Share by Type (2014-2019)
      • 5.2 Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Type (2014-2019)
      • 5.3 Global Diabetic Peripheral Neuropathy Treatment Price by Type (2014-2019)
      • 5.4 Global Diabetic Peripheral Neuropathy Treatment Production Growth by Type (2014-2019)

      6 Global Diabetic Peripheral Neuropathy Treatment Market Analysis by Applications

      • 6.1 Global Diabetic Peripheral Neuropathy Treatment Consumption Market Share by Application (2014-2019)
      • 6.2 Global Diabetic Peripheral Neuropathy Treatment Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Diabetic Peripheral Neuropathy Treatment Business

      • 7.1 Achelios Therapeutics Inc
        • 7.1.1 Achelios Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
        • 7.1.2 Diabetic Peripheral Neuropathy Treatment Product Introduction, Application and Specification
        • 7.1.3 Achelios Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Celgene Corp
        • 7.2.1 Celgene Corp Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
        • 7.2.2 Diabetic Peripheral Neuropathy Treatment Product Introduction, Application and Specification
        • 7.2.3 Celgene Corp Diabetic Peripheral Neuropathy Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Commence Bio Inc
        • 7.3.1 Commence Bio Inc Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
        • 7.3.2 Diabetic Peripheral Neuropathy Treatment Product Introduction, Application and Specification
        • 7.3.3 Commence Bio Inc Diabetic Peripheral Neuropathy Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Grunenthal GmbH
        • 7.4.1 Grunenthal GmbH Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
        • 7.4.2 Diabetic Peripheral Neuropathy Treatment Product Introduction, Application and Specification
        • 7.4.3 Grunenthal GmbH Diabetic Peripheral Neuropathy Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Immune Pharmaceuticals Inc
        • 7.5.1 Immune Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
        • 7.5.2 Diabetic Peripheral Neuropathy Treatment Product Introduction, Application and Specification
        • 7.5.3 Immune Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 KPI Therapeutics Inc
        • 7.6.1 KPI Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
        • 7.6.2 Diabetic Peripheral Neuropathy Treatment Product Introduction, Application and Specification
        • 7.6.3 KPI Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Medifron DBT Co Ltd
        • 7.7.1 Medifron DBT Co Ltd Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
        • 7.7.2 Diabetic Peripheral Neuropathy Treatment Product Introduction, Application and Specification
        • 7.7.3 Medifron DBT Co Ltd Diabetic Peripheral Neuropathy Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Mitsubishi Tanabe Pharma Corp
        • 7.8.1 Mitsubishi Tanabe Pharma Corp Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
        • 7.8.2 Diabetic Peripheral Neuropathy Treatment Product Introduction, Application and Specification
        • 7.8.3 Mitsubishi Tanabe Pharma Corp Diabetic Peripheral Neuropathy Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Novaremed Ltd
        • 7.9.1 Novaremed Ltd Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
        • 7.9.2 Diabetic Peripheral Neuropathy Treatment Product Introduction, Application and Specification
        • 7.9.3 Novaremed Ltd Diabetic Peripheral Neuropathy Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Reata Pharmaceuticals Inc
        • 7.10.1 Reata Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
        • 7.10.2 Diabetic Peripheral Neuropathy Treatment Product Introduction, Application and Specification
        • 7.10.3 Reata Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Relief Therapeutics Holding AG
      • 7.12 ViroMed Co Ltd

      8 Diabetic Peripheral Neuropathy Treatment Manufacturing Cost Analysis

      • 8.1 Diabetic Peripheral Neuropathy Treatment Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Diabetic Peripheral Neuropathy Treatment
      • 8.4 Diabetic Peripheral Neuropathy Treatment Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Diabetic Peripheral Neuropathy Treatment Distributors List
      • 9.3 Diabetic Peripheral Neuropathy Treatment Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Diabetic Peripheral Neuropathy Treatment Market Forecast

      • 11.1 Global Diabetic Peripheral Neuropathy Treatment Production, Revenue Forecast
        • 11.1.1 Global Diabetic Peripheral Neuropathy Treatment Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Diabetic Peripheral Neuropathy Treatment Price and Trend Forecast (2019-2025)
      • 11.2 Global Diabetic Peripheral Neuropathy Treatment Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Diabetic Peripheral Neuropathy Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Diabetic Peripheral Neuropathy Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Diabetic Peripheral Neuropathy Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Diabetic Peripheral Neuropathy Treatment Production, Revenue Forecast (2019-2025)
      • 11.3 Global Diabetic Peripheral Neuropathy Treatment Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Diabetic Peripheral Neuropathy Treatment Consumption Forecast (2019-2025)
        • 11.3.2 Europe Diabetic Peripheral Neuropathy Treatment Consumption Forecast (2019-2025)
        • 11.3.3 China Diabetic Peripheral Neuropathy Treatment Consumption Forecast (2019-2025)
        • 11.3.4 Japan Diabetic Peripheral Neuropathy Treatment Consumption Forecast (2019-2025)
      • 11.4 Global Diabetic Peripheral Neuropathy Treatment Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Diabetic Peripheral Neuropathy Treatment Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Diabetic Peripheral Neuropathy Treatment market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Diabetic Peripheral Neuropathy Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Diabetic Peripheral Neuropathy Treatment market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Achelios Therapeutics Inc
        Celgene Corp
        Commence Bio Inc
        Grunenthal GmbH
        Immune Pharmaceuticals Inc
        KPI Therapeutics Inc
        Medifron DBT Co Ltd
        Mitsubishi Tanabe Pharma Corp
        Novaremed Ltd
        Reata Pharmaceuticals Inc
        Relief Therapeutics Holding AG
        ViroMed Co Ltd

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Antimunocel
        ASP-8477
        BNV-222
        Capsaicin
        CBX-129801
        Others

        Segment by Application
        Hospital
        Clinic
        Others

        Buy now